These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15387372)

  • 1. Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.
    Yokoyama T; Nakamura H; Otani Y; Kubota T; Fujimoto N; Seiki M; Kitajima M; Okada Y
    Clin Exp Metastasis; 2004; 21(3):223-33. PubMed ID: 15387372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
    J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
    Noda K; Ishida S; Inoue M; Obata K; Oguchi Y; Okada Y; Ikeda E
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2163-70. PubMed ID: 12714657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH; Liao EY
    Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation.
    Longin J; Guillaumot P; Chauvin MA; Morera AM; Le Magueresse-Battistoni B
    J Cell Sci; 2001 Jun; 114(Pt 11):2125-34. PubMed ID: 11493648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
    Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
    Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
    Ueno H; Yamashita K; Azumano I; Inoue M; Okada Y
    Int J Cancer; 1999 Oct; 84(5):470-7. PubMed ID: 10502722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y; Binner S; Nagase H
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.